WAT · Earnings call · 2026Q2T · Full report

Acquisition and Partnership

WATERS CORP /DE/ · 2026-08-04 · Importance 31 · Surprise 42

Waters announced a strategic partnership with IMU Biosciences to support immune profiling and AI-enabled precision medicine in clinical diagnostics. IMU has raised more than $50 million and is working to decode the immune system through large-scale immune and disease datasets. The partners intend to scale a precision-immunology platform for population-wide immune mapping and disease characterization, which Waters views as an entry point into a high-growth biosciences adjacency.

Key facts